Download PDF
CC BY 4.0 · VCOT Open 2019; 02(02): e16-e24
DOI: 10.1055/s-0039-1693441
Original Article
Georg Thieme Verlag KG Stuttgart · New York

Mitigation of Antibiotic-Inducted Toxicity in Equine Chondrocytes by Soybean/Glucosamine/Chondroitin Combination

Cathleen A. Mochal-King
1   College of Veterinary Medicine, Mississippi State University, Mississippi State, Mississippi, United States
,
Ann M. Rashmir 
2   College of Veterinary Medicine, Michigan State University, East Lansing, Michigan, United States
,
Lowella V. Fortuno
3   Department of Research and Development, Nutramax Laboratories, Inc., Edgewood, Maryland, United States
,
Mark W. Grzanna
3   Department of Research and Development, Nutramax Laboratories, Inc., Edgewood, Maryland, United States
,
Angela Y. Au
3   Department of Research and Development, Nutramax Laboratories, Inc., Edgewood, Maryland, United States
4   Department of Bioengineering, Syracuse University, Syracuse, New York, United States
5   Department of Orthopedic Surgery, Johns Hopkins University, Baltimore, Maryland, United States
,
Jillian Dougherty
1   College of Veterinary Medicine, Mississippi State University, Mississippi State, Mississippi, United States
6   Veterinary Emergency and Specialty Centers of New Mexico, Albuquerque, New Mexico, United States
,
Carmelita G. Frondoza
1   College of Veterinary Medicine, Mississippi State University, Mississippi State, Mississippi, United States
3   Department of Research and Development, Nutramax Laboratories, Inc., Edgewood, Maryland, United States
5   Department of Orthopedic Surgery, Johns Hopkins University, Baltimore, Maryland, United States
› Author Affiliations Funding This project was funded by Nutramax Laboratories, Inc., Michigan State University and Mississippi State University.
Further Information

Publication History

21 January 2019

04 June 2019

Publication Date:
23 July 2019 (online)

   Permissions and Reprints

Abstract

Objectives The aim of this study was to evaluate the effect of amikacin (AK) and enrofloxacin (EF) at concentrations consistent with those obtained by intra-articular and intravenous regional limb perfusion on both cytotoxicity and prostaglandin E2 (PGE2) production by equine chondrocytes. This study also determines if PGE2 production could be reduced by avocado/soybean unsaponifiables (ASU), glucosamine (GLU) and chondroitin sulphate (CS).

Study Design Chondrocytes were grown in monolayer from the articular cartilage of 12 horses and treated with clinically relevant concentrations of AK and EF, with or without the combination of ASU + GLU + CS. Positive controls consisted of chondrocytes that were activated with lipopolysaccharide (LPS). Chondrocyte response was evaluated using both MTT cytotoxicity assay and immunoassay for PGE2 production.

Results Amikacin and EF generated a dose-dependent cytotoxicity. Amikacin induced 90% cell death at a concentration of 25 mg/mL. Enrofloxacin induced 90% cell death at 1.0 mg/mL and 98% cell death at 10 mg/mL (p < 0.05). Amikacin failed to induce PGE2 production at any of the concentrations studied. In contrast, EF and the positive control (LPS) induced PGE2 production at all concentrations. Induction of PGE2 by EF at all concentrations was significantly reduced (p < 0.05) by pre-treatment with ASU + GLU + CS.

Conclusions and Clinical Relevance Horses receiving commonly used dosages of AK and EF may benefit from administration of ASU + GLU + CS.

Keywords

equine - chondrocyte - antibiotic medications - inflammation - PGE2

Author Contribution

The idea for the project was originated by Ann Rashmir. Experimental design was conceived by Carmelita Frondoza, Ann Rashmir and Cathleen Mochal. Acquisition of the data and data analysis were performed by Cathleen A. Mochal-King, Angela Au, Lowella Fortuno, Mark Grzanna, Carmelita Frondoza and Jillian Dougherty. Cathleen Mochal, Carmelita Frondoza and Ann Rashmir interpreted the data and prepared the manuscript. All authors reviewed the manuscript.


 

  • References

  • 1 Brunsting JY, Pille FJ, Oosterlinck M, Haspeslagh M, Wilderjans HC. Incidence and risk factors of surgical site infection and septic arthritis after elective arthroscopy in horses. Vet Surg 2018; 47 (01) 52-59
    CrossrefPubMedGoogle Scholar
  • 2 Bolt DM, Ishihara A, Weisbrode SE, Bertone AL. Effects of triamcinolone acetonide, sodium hyaluronate, amikacin sulfate, and mepivacaine hydrochloride, alone and in combination, on morphology and matrix composition of lipopolysaccharide-challenged and unchallenged equine articular cartilage explants. Am J Vet Res 2008; 69 (07) 861-867
    CrossrefPubMedGoogle Scholar
  • 3 du Souich P, García AG, Vergés J, Montell E. Immunomodulatory and anti-inflammatory effects of chondroitin sulphate. J Cell Mol Med 2009; 13 (8A): 1451-1463
    CrossrefPubMedGoogle Scholar
  • 4 Xing W, Hao L, Yang X, Li F, Huo H. Glucocorticoids induce apoptosis by inhibiting microRNA cluster miR‑17‑92 expression in chondrocytic cells. Mol Med Rep 2014; 10 (02) 881-886
    CrossrefPubMedGoogle Scholar
  • 5 Caron JP, Bolin CA, Hauptman JG, Johnston KA. Minimum inhibitory concentration and postantibiotic effect of amikacin for equine isolates of methicillin-resistant Staphylococcus aureus in vitro. Vet Surg 2009; 38 (05) 664-669
    CrossrefPubMedGoogle Scholar
  • 6 Taintor J, Schumacher J, DeGraves F. Comparison of amikacin concentrations in normal and inflamed joints of horses following intra-articular administration. Equine Vet J 2006; 38 (02) 189-191
    PubMedGoogle Scholar
  • 7 Beccar-Varela AM, Epstein KL, White CL. Effect of experimentally induced synovitis on amikacin concentrations after intravenous regional limb perfusion. Vet Surg 2011; 40 (07) 891-897
    PubMedGoogle Scholar
  • 8 Errico JA, Trumble TN, Bueno AC, Davis JL, Brown MP. Comparison of two indirect techniques for local delivery of a high dose of an antimicrobial in the distal portion of forelimbs of horses. Am J Vet Res 2008; 69 (03) 334-342
    CrossrefPubMedGoogle Scholar
  • 9 Kilcoyne I, Nieto JE, Knych HK, Dechant JE. Time required to achieve maximum concentration of amikacin in synovial fluid of the distal interphalangeal joint after intravenous regional limb perfusion in horses. Am J Vet Res 2018; 79 (03) 282-286
    CrossrefPubMedGoogle Scholar
  • 10 Sanchez Teran AF, Rubio-Martinez LM, Villarino NF, Sanz MG. Effects of repeated intra-articular administration of amikacin on serum amyloid A, total protein and nucleated cell count in synovial fluid from healthy horses. Equine Vet J Suppl 2012; (43) 12-16
    PubMedGoogle Scholar
  • 11 Giguère S, Sweeney RW, Habecker PL, Lucas J, Richardson DW. Tolerability of orally administered enrofloxacin in adult horses: a pilot study. J Vet Pharmacol Ther 1999; 22 (05) 343-347
    CrossrefPubMedGoogle Scholar
  • 12 Kaartinen L, Panu S, Pyörälä S. Pharmacokinetics of enrofloxacin in horses after single intravenous and intramuscular administration. Equine Vet J 1997; 29 (05) 378-381
    CrossrefPubMedGoogle Scholar
  • 13 Parra-Sanchez A, Lugo J, Boothe DM. , et al. Pharmacokinetics and pharmacodynamics of enrofloxacin and a low dose of amikacin administered via regional intravenous limb perfusion in standing horses. Am J Vet Res 2006; 67 (10) 1687-1695
    CrossrefPubMedGoogle Scholar
  • 14 Beluche LA, Bertone AL, Anderson DE, Kohn CW, Weisbrode SE. In vitro dose-dependent effects of enrofloxacin on equine articular cartilage. Am J Vet Res 1999; 60 (05) 577-582
    PubMedGoogle Scholar
  • 15 Khazaeel K, Mazaheri Y, Hashemi Tabar M, Najafzadeh H, Morovvati H, Ghadrdan A. Effect of enrofloxacin on histochemistry, immunohistochemistry and molecular changes in lamb articular cartilage. Acta Med Iran 2015; 53 (09) 555-561
    PubMedGoogle Scholar
  • 16 Maślanka T, Jaroszewski JJ, Mikołajczyk A, Rotkiewicz T. Effect of increasing doses of enrofloxacin on chicken articular cartilage. Pol J Vet Sci 2009; 12 (01) 21-33
    PubMedGoogle Scholar
  • 17 Egerbacher M, Edinger J, Tschulenk W. Effects of enrofloxacin and ciprofloxacin hydrochloride on canine and equine chondrocytes in culture. Am J Vet Res 2001; 62 (05) 704-708
    CrossrefPubMedGoogle Scholar
  • 18 Torzilli PA, Tehrany AM, Grigiene R, Young E. Effects of misoprostol and prostaglandin E2 on proteoglycan biosynthesis and loss in unloaded and loaded articular cartilage explants. Prostaglandins 1996; 52 (03) 157-173
    CrossrefPubMedGoogle Scholar
  • 19 Tung JT, Venta PJ, Eberhart SW, Yuzbasiyan-Gurkan V, Alexander L, Caron JP. Effects of anti-arthritis preparations on gene expression and enzyme activity of cyclooxygenase-2 in cultured equine chondrocytes. Am J Vet Res 2002; 63 (08) 1134-1139
    CrossrefPubMedGoogle Scholar
  • 20 van de Water E, Oosterlinck M, Dumoulin M. , et al. The preventive effects of two nutraceuticals on experimentally induced acute synovitis. Equine Vet J 2017; 49 (04) 532-538
    CrossrefPubMedGoogle Scholar
  • 21 Au RY, Al-Talib TK, Au AY, Phan PV, Frondoza CG. Avocado soybean unsaponifiables (ASU) suppress TNF-alpha, IL-1beta, COX-2, iNOS gene expression, and prostaglandin E2 and nitric oxide production in articular chondrocytes and monocyte/macrophages. Osteoarthritis Cartilage 2007; 15 (11) 1249-1255
    CrossrefPubMedGoogle Scholar
  • 22 Gustafson SB, McIlwraith CW, Jones RL. Comparison of the effect of polysulfated glycosaminoglycan, corticosteroids, and sodium hyaluronate in the potentiation of a subinfective dose of Staphylococcus aureus in the midcarpal joint of horses. Am J Vet Res 1989; 50 (12) 2014-2017
    PubMedGoogle Scholar
  • 23 Frondoza CG, Fortuno LV, Grzanna MW, Ownby SL, Au AY, Rashmir-Raven AM. α-Lipoic acid potentiates the anti-inflammatory activity of avocado/soybean unsaponifiables in chondrocyte cultures. Cartilage 2018; 9 (03) 304-312
    CrossrefPubMedGoogle Scholar
  • 24 Chen AL, Robbins MI, Zhang Z. The effects of FCHG49 glucosamine-TRH122, chondroitin sulfate-NMX1000 avocado soybean unsaponifiables on symptomatic chondral defects in elite ski jumpers. J Prev Med Public Health 2017; 1 (04) 1017
    PubMedGoogle Scholar
  • 25 Fransen M, Agaliotis M, Nairn L. , et al; LEGS study collaborative group. Glucosamine and chondroitin for knee osteoarthritis: a double-blind randomised placebo-controlled clinical trial evaluating single and combination regimens. Ann Rheum Dis 2015; 74 (05) 851-858
    PubMedGoogle Scholar
  • 26 Heinecke LF, Grzanna MW, Au AY, Mochal CA, Rashmir-Raven A, Frondoza CG. Inhibition of cyclooxygenase-2 expression and prostaglandin E2 production in chondrocytes by avocado soybean unsaponifiables and epigallocatechin gallate. Osteoarthritis Cartilage 2010; 18 (02) 220-227
    CrossrefPubMedGoogle Scholar
  • 27 Lee AS, Ellman MB, Yan D. , et al. A current review of molecular mechanisms regarding osteoarthritis and pain. Gene 2013; 527 (02) 440-447
    CrossrefPubMedGoogle Scholar
  • 28 Secor EJ, Grzanna MW, Rashmir-Raven AM, Frondoza CG. Chondrocyte production of pro-inflammatory chemokine MCP-1 (CCL-2) and prostaglandin e-2 is inhibited by avocado/soybean unsaponifiables, glucosamine, chondroitin sulfate combination. Pharmacol Pharm 2018; 9: 10-26
    CrossrefPubMedGoogle Scholar
  • 29 Eitner A, Hofmann GO, Schaible HG. Mechanisms of osteoarthritic pain. Studies in humans and experimental models. Front Mol Neurosci 2017; 10: 349
    CrossrefPubMedGoogle Scholar
  • 30 Attur M, Al-Mussawir HE, Patel J. , et al. Prostaglandin E2 exerts catabolic effects in osteoarthritis cartilage: evidence for signaling via the EP4 receptor. J Immunol 2008; 181 (07) 5082-5088
    CrossrefPubMedGoogle Scholar
  • 31 Kapoor M, Martel-Pelletier J, Lajeunesse D, Pelletier JP, Fahmi H. Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat Rev Rheumatol 2011; 7 (01) 33-42
    CrossrefPubMedGoogle Scholar
  • 32 Marlovits S, Hombauer M, Truppe M, Vècsei V, Schlegel W. Changes in the ratio of type-I and type-II collagen expression during monolayer culture of human chondrocytes. J Bone Joint Surg Br 2004; 86 (02) 286-295
    PubMedGoogle Scholar
  • 33 Cheng T, Maddox NC, Wong AW, Rahnama R, Kuo AC. Comparison of gene expression patterns in articular cartilage and dedifferentiated articular chondrocytes. J Orthop Res 2012; 30 (02) 234-245
    CrossrefPubMedGoogle Scholar
  • 34 Chan PS, Caron JP, Orth MW. Effects of glucosamine and chondroitin sulfate on bovine cartilage explants under long-term culture conditions. Am J Vet Res 2007; 68 (07) 709-715
    CrossrefPubMedGoogle Scholar
  • 35 Kawcak CE, Frisbie DD, McIlwraith CW, Werpy NM, Park RD. Evaluation of avocado and soybean unsaponifiable extracts for treatment of horses with experimentally induced osteoarthritis. Am J Vet Res 2007; 68 (06) 598-604
    CrossrefPubMedGoogle Scholar
  • 36 Laverty S, Sandy JD, Celeste C, Vachon P, Marier JF, Plaas AH. Synovial fluid levels and serum pharmacokinetics in a large animal model following treatment with oral glucosamine at clinically relevant doses. Arthritis Rheum 2005; 52 (01) 181-191
    CrossrefPubMedGoogle Scholar
  • 37 Adebowale A, Du J, Liang Z, Leslie JL, Eddington ND. The bioavailability and pharmacokinetics of glucosamine hydrochloride and low molecular weight chondroitin sulfate after single and multiple doses to beagle dogs. Biopharm Drug Dispos 2002; 23 (06) 217-225
    CrossrefPubMedGoogle Scholar